Table of Contents |
|
Content |
Page |
CHAPTER ONE:. 1
INTRODUCTION AND LITERATURE REVIEW… 1
1.1 . Nanotechnology. 2
1.2 . Nanomaterials. 2
1.2.1 . ZnO nanoparticles. 3
1.2.2 . CuxO nanoparticles (x=1, 2). 6
1.2.3 . CuXO/ZnO nanoparticles. 9
1.3 . A brief review onpropargylamines. 11
1.4 . A brief review ontriazoles. 19
1.5 . A brief review ontetrazoles. 23
1.6 . A brief review onbenzoxazoles and 2-oxazolines. 27
1.7 .A brief review ondiaryl ethers. 29
1.8 . A brief review on arylation of imidazole. 34
1.9 . A brief review onorganophosphorus heterocycles. 38
1.10 . The Objective of This Study. 40
CHAPTER TWO: EXPRIMENTAL.. 41
2.1 . General 42
2.2 . General procedure for the synthesis of nano Cu2O.. 43
2.3 . General procedure for the synthesis of nano ZnO.. 43
2.4 . General procedure for the synthesis of nano Cu2O/ZnO.. 43
2.5 . General procedure for the synthesis of nano CuO/ZnO.. 44
2.6 . General procedure for the three-component synthesis of propargylamines using ZnO: 44
2.7 . General procedure for the three-component synthesis of propargylamines containing atertiary carbon center using nano Cu2O/ZnO: 45
2.7.1 . Physical data of representative products (4a-s and 5a-m): 46
2.8 . General procedure for the catalytic N-arylation of nitrogen-containing heterocycles witharyl halides andarylboronic acid: 57
2.8.1 . Physical data of representative products (8a-n): 57
2.9 . General procedure for thesynthesis of diaryl ether: 61
2.9.1 . Physical data of representative products(10a-o): 61
2.10 . General procedure for the synthesis of 5-substituted-1H-tetrazoles: 65
2.10.1 . Physical data of representative products(12a-o): 65
2.11 . General procedure for the synthesis of 2-arylbenzoxazole: 71
2.11.1 . Physical data of representative products(15a-i): 71
2.12 . General procedure for the synthesis of 2-oxazolines (16a-k): 74
2.12.1 . Physical data of representative products (16a-k): 74
2.13 . General procedure for the one-pot synthesis 1,2,3-triazoles of aryl boronic acids: 76
2.13.1 . Physical data of representative products: 77
2.14 . General procedure for the synthesis of 3-amino-2-hydroxy-2,3-dihydrobenzo[d][1,2]oxaphosphole 2-oxides: 83
2.14.1 . Physical data of representative products (20b, 20c): 83
CHAPTER THREE:. 85
RESULTS AND DISSCUSION.. 85
3.1 . Mixed metal oxide nanoparticles: 86
3.2 . Preparation and chracterization of nano Cu2O/ZnO: 86
3.2.1 . XRD analysisof Cu2O/ZnO nanoflake: 86
3.2.2 . SEM and TEMof Cu2O/ZnO nanoflake: 87
3.2.3 . FT-IR spectrumof Cu2O/ZnO nanoflake: 88
3.2.4 . Specific surface area of Cu2O/ZnO nanoflake: 89
3.2.5 . ICP analysis of Cu2O/ZnO nanoflake: 90
3.3 . Preparation and chracterization of nano CuO/ZnO: 90
3.3.1 . XRD analysis of CuO/ZnO nanosphere: 91
3.3.2 . SEM and TEM of CuO/ZnO nanosphere: 92
3.3.3 . FT-IR spectrum of CuO/ZnO nanosphere: 93
3.3.4 . Specific surface area of CuO/ZnO nanosphere: 94
3.3.5 . ICP analysis of CuO/ZnO nanosphere: 95
3.4 . Catalytic reactivity of nano Cu2O/ZnO: 95
3.4.1 . Coupling of aldehydes/or ketones, secondary amines, and terminal alkynes under solvent-free conditions catalyzed by nano Cu2O/ZnO: 95
3.4.1.1 . One-pot multi-component route to propargylamines using zinc oxide under solvent-free conditions: 109
3.4.2 . Nano Cu2O/ZnOas heterogeneous catalyst for the N-arylation of heterocycles with aryl halides and arylboronic acids in the absence of additional ligand in air: 119
3.4.3 . Nano Cu2O/ZnO as heterogeneous catalyst for the synthesis of diaryl ethers: 131
3.4.4 . Nano Cu2O/ZnO as heterogeneous catalyst for the synthesis of tetrazole derivatives: 140
3.4.5 . Nano Cu2O/ZnO as heterogeneous catalyst for the synthesis of oxazoline and benzoxazolederivatives: 145
3.5 . Nano Cu2O/ZnO catalyzed homocoupling reaction of terminal alkynes: 151
3.6 . Catalytic reactivity of nano CuO/ZnO: 154
3.6.1 . Nano CuO/ZnO catalyzed one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles from in situ generated azides: 154
3.6.2 . Nano CuO/ZnO catalyzed one-pot, three component synthesis of heterocyclic α-aminophosphonates: 159
3.7 . Unsuccessfull Reactions. 164
List of Schemes |
|
Scheme |
Page |
Scheme 1.1. Synthesis of 3-indolyl-3-hydroxy oxindoles catalyzed by nano-rod ZnO. 5
Scheme 1.2. Synthesis of 2-amino-4H-chromen-4-yl phosphonats using nano-rod ZnO. 6
Scheme 1.3. Cu-catalyzed couplings of aryl iodonium salts with sodium trifluoromethanesulfinate. 8
Scheme 1.4. Copper-catalyzed synthesis of quinazolines in water starting from o-bromobenzylbromides and benzamidines. 9
Scheme 1.5. C-Arylation reactions catalyzed by CuO-nanoparticles under ligand free conditions. 9
Scheme 1.6. Nano copper oxide catalyzed synthesis of symmetrical diaryl sulfides under ligand free conditions. 9
Scheme 1.7. Azide–alkyne cycloaddition reactions catalyzed by the ZnO–CuO hybrid nanocatalysts under ultrasonic irradiation. 11
Scheme 1.8. Various procedures for the synthesis of propargylamines. 12
Scheme 1.9. Tentative mechanism of the A3-coupling. 13
Scheme 1.10. A3-coupling with polymer-supported aryl alkynes. 14
Scheme 1.11. CuBr-RuCl3-co-catalyzed A3-coupling for the synthesis of N-arylpropargylamines. 14
Scheme 1.12. AuBr3-catalyzed A3-coupling for the synthesis of tertiary propargylamines. 15
Scheme 1.13. AgI-catalyzed A3-coupling for the synthesis of propargylamines. 15
Scheme 1.14. Universal microwave-assisted CuI-catalyzed A3-coupling protocol. 16
Scheme 1.15. Recyclability of the CuCN catalyst in the A3-coupling process employing an ionic liquid. 17
Scheme 1.16. Microwave-assisted CuBr-catalyzed A3-coupling for the synthesis of secondary N-alkylpropargylamines. 18
Scheme 1.17. Synthesis of propargylamines catalyzed by nanocrystalline copper(II) oxide. 18
Scheme 1.18. Synthesis of triazolylcoumarins by CuAAC. 20
Scheme 1.19. Thermal 1,3-dipolar Huisgen cycloaddition between alkynes and azides. 20
Scheme 1.20. Cu(I)-catalyzed azide–alkyne cycloaddition. 21
Scheme 1.21. Synthesis of triazoles using bimetallic Pd(0)–Cu(I) catalyst. 21
Scheme 1.22. Synthesis of triazoles using microwave assisted Cu(0)–Cu(II). 21
Scheme 1.23. Microwave-assisted three-component synthesis of 1,4-disubstituted 1,2,3-triazoles. 22
Scheme 1.24. Solvent-free synthesis of triazoles using a polymer-supported copper (I) iodide. 22
Scheme 1.25. One-pot synthesis of 1,2,3-triazoles using copper catalysts in water. 23
Scheme 1.26. One-pot synthesis of 1,4-disubstituted 1,2,3-triazoles. 23
Scheme 1.27. Clay-Cu(II)/NaN3 catalyzed aromatic azidonation and azide-alkyne cycloaddition. 23
Scheme 1.28. Preparation of 5-substituted 1H-tetrazoles from the corresponding nitriles and NaN3. 25
Scheme 1.29. TBAF-catalyzed reaction of benzonitrile with TMSN3 under solvent less condition. 25
Scheme 1.30. CuI-catalyzed reaction of nitriles with trimethylsilyl azide. 26
Scheme 1.31. Synthesis of 5-substituted 1H-tetrazole with γ -Fe2O3. 26
Scheme 1.32. Synthesis of 5-substituted tetrazoles catalyzed by Cu–Zn alloy nanopowder. 26
Scheme 1.33. Synthesis of 5-substituted tetrazoles catalyzed by AMWCNTs-O-Cu(II)-PhTPY. 27
Scheme 1.34. Preparation of 2-oxazines and 2-oxazolines. 28
Scheme 1.35. Synthesis of aryl 2-oxazolines catalyzed by Pd/Fe3O4. 29
Scheme 1.36. Palladium-catalyzed multicomponent process for the preparation of oxazolines and benzoxazoles. 29
Scheme 1.37. Copper(I)/diketone-based catalytic systems developed by Buchwald. 31
Scheme 1.38. Copper(I)/diketone-based catalytic systems developed by Bao. 31
Scheme 1.39. Copper(I)/diketone-based catalytic systems developed by Taillefer. 32
Scheme 1.40. Copper(I) bromide/ligand systems developed by Ding. 32
Scheme 1.41. Etherification of aryl bromides catalysed by CuSAr after 6 h. 33
Scheme 1.42. Room temperature, metal-free synthesis of diaryl ethers with use of diaryliodonium salts. 33
Scheme 1.43. Synthesis of polyfluoro-substituted unsymmetrical biaryl ethers. 34
Scheme 1.44. Copper-catalyzed arylation of imidazoles by aryl halides. 35
Scheme 1.45. Cu2O-catalyzed arylation of imidazoles by aryl halides. 36
Scheme 1.46. CuI-catalyzed N-arylation of imidazole, pyrazole and benzimidazole with aryl bromides. 37
Scheme 1.47. CuSO4-catalyzed arylation of imidazoles with aryl halides. 37
Scheme 1.48. Cu(OAc)2.H2O-catalyzed arylation of nitrogen-containing heterocycles with aryl iodides. 38
Scheme 1.49. Cyclization of allenic phosphonic acids with different electrophiles. 39
Scheme 1.50. Synthesis of 3-amino-2-hydroxy-2,3-dihydrobenzo[d][1,2]oxaphosphole 2-oxides. 39
Scheme 3.1. Synthesis of propargylamines catalyzed by Cu2O/ZnO nanoflake under solvent-free condition. 96
Scheme 3.2. Three-component coupling of benzaldehyde, piperidine and phenylacetylene. 96
Scheme 3.3. Synthesis of propargylamines catalyzed by ZnO under solvent-free condition. 109
Scheme 3.4. A proposed mechanism of the ZnO-catalyzed synthesis of propargylamine. 117
Scheme 3.5. Synthesis of N-aryl heterocycles in air catalyzed by Cu2O/ZnO nanoflake. 119
Scheme 3.6. Reaction conditions for synthesis of diaryl ether. 131
Scheme 3.7. Nano Cu2O/ZnO catalyzed synthesis of 5-substituted 1H-tetrazoles. 140
Scheme 3.8. Synthesis of 2-oxazolines and benzoxazoles from the reaction of aromatic nitriles with 2-aminoalcohols and 2-aminophenols. 146
Scheme 3.9. Nano Cu2O/ZnO -catalyzed homocoupling of phenylacetylene. 152
Scheme 3.10. One-pot synthesis of 1,4-disubstituted 1,2,3-triazoles. 155
Scheme 3.11. Synthesis of 3-amino-2-hydroxy-2,3-dihydrobenzo[d][1,2]oxaphosphole 2-oxides. 160
List of Figures |
|
Figure |
Page |
Figure 1.1.The crystal structure of ZnO (a): Wurtzite structure, (b): Zinc blend unit cell, (c): Rocksalt structure. 4
Figure 1.2. Various morphologies of ZnO nanostructure, including (a): nanotube (b): hierarchical (c): nanobelt (d): nanorod (e): nanocomb and (f): nanowire. 5
Figure 1.3. Crystal structure of Left: CuO, monoclinic stucture. Right: Cu2O, Cubicstructure. 7
Figure 1.4. Propargylamine inhibitors of type-B monoamine oxidase. 11
Figure 1.5. Two examples of 1,2,3-triazoles with anti-HIV properties. 19
Figure 1.6. Examples of pharmaceutically relevant biphenyl tetrazoles. 24
Figure 1.7. Example of several biological compounds. 27
Figure 1.8. Selected biologically active diaryl ethers. 30
Figure 1.9. Structures of some well-khown imidazoles containing bioactive molecules. 34
Figure 1.10. The structures of some ligands for arylation of N-heterocycles. 36
Figure 3.1. XRD pattren of Cu2O/ZnO nanoflake. 87
Figure 3.2. The SEM image of Cu2O/ZnO nanoflake. 88
Figure 3.3. TEM image of Cu2O/ZnO nanoflake. 88
Figure 3.4. FT-IR spectrum of Cu2O/ZnO nanoflake. 89
Figure 3.5. The XRD pattern of CuO/ZnO nanosphere. 92
Figure 3.6. The SEM image of CuO/ZnOnanosphere. 93
Figure 3.7. The TEM image of CuO/ZnOnanosphere. 93
Figure 3.8. FT-IR spectrum of CuO/ZnOnanosphere. 94
Figure 3.9. Recyclability of Cu2O/ZnO nanoparticle for propargylamine synthesis 100
Figure 3.10. Comparison of FT-IR spectrum of Cu2O/ZnO nanoflake, A: before and B: after 10 times reuses. 101
Figure 3.11. The XRD pattern of Cu2O/ZnO nanoflake:a: before and b:after 10 times reuses. 101
Figure 3.12. The XRD pattern of Cu2O/ZnO nanoflake after 6 times reuses. 124
Figure 3.13. The XRD pattern of Cu2O/ZnO nanoflake: a) before and b) after 5 times reuses. 138
Figure 3.14. The XRD pattern of Cu2O/ZnO nanoflake:a: before and b:after 5 times reuses. 145
List of Tables |
|
Table |
Page |